Pharmacogenetics and Inflammatory Bowel Diseases in Adults and Children: Diagnosis and Treatment Prospects

Pharmacogenetics and Inflammatory Bowel Diseases in Adults and Children: Diagnosis and Treatment Prospects

The article highlights modern concepts of inflammatory diseases in adults and children in terms of genetic possibilities for diagnosing Crohn's disease and ulcerative colitis. It names the main candidate genes, which, in the presence of their specific polymorphisms, indicate the occurrence of a...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. Yu. Serebrova, A. B. Prokofiev, M. V. Zhuravleva, R. E. Kazakov, I. V. Suchinava, G. I. Gorodetskaya, N. N. Eremenko, N. B. Lazareva, L. R. Galstyan, E. A. Smolyarchuk, D. O. Kurguzova, A. O. Barkov
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	inflammatory bowel disease ulcerative colitis crohn's disease pharmacogenetics polymorphisms 5-asa mesalazine immunomodulators glucocorticosteroids monoclonal antibodies 5-аск
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/18
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
by: Yu. P. Uspenskiy, et al.
Published: (2022-03-01)

Probiotics for Preventing Relapse in Ulcerative Colitis: A Systematic Review and Bayesian Network Meta-Analysis
by: Steven Alvianto, et al.
Published: (2025-08-01)

Unraveling the Etiology of Acute Pancreatitis in the Context of Crohn’s Disease: Therapy versus Disease
by: Andrada Georgiana BADEA, et al.
Published: (2025-03-01)

Pharmacogenetics of chemical addictions
by: E. M. Krupitsky, et al.
Published: (2019-12-01)

Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease
by: N. A. Shatalova, et al.
Published: (2023-11-01)

Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01)

Progress in pharmacogenetic studies on effect on tacrolimus concentrations
by: YANG Shuang, et al.
Published: (2020-01-01)

The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01)

Diverticular disease of the large intestine: current state of the problem
by: N. A. Lysov, et al.
Published: (2020-12-01)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
by: D. A. Sychev, et al.
Published: (2015-09-01)

POTENTIAL OF PHARMACOGENETICS IN THE CORRECTION OF ANTICOAGULANT THERAPY AMONG PATIENT WITH PROSTHETIC HEART VALVES
by: I. Yu. Zhuravleva, et al.
Published: (2013-06-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Clinical pharmacogenetics of antiaggregants: clinical pharmacologist' point of view
by: D. A. Syche, et al.
Published: (2007-08-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)

Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01)

Pharmacogenetic Aspects of Postoperative Anesthesia with Ketoprofen in Cardiac Surgery Patients
by: T. E. Morozova, et al.
Published: (2021-11-01)

Features of rectal treatment of inflammatory bowel diseases
by: D. V. Egorov, et al.
Published: (2023-07-01)

Pharmacogenetics of cerebrovascular metabolism modulators in dementia due to Alzheimer’s disease
by: Fabricio Ferreira de Oliveira
Published: (2015-03-01)

Pharmacogenetics of hypoglycemic agents
by: Irina Vladimirovna Kononenko, et al.
Published: (2015-12-01)

Therapeutic resistance in depression from the genetics and pharmacogenetics point of view
by: G. E. Mazo, et al.
Published: (2019-12-01)

Population biobank as a basis for determining spatial variation of clinically relevant pharmacogenetic biomarkers of cardiovascular diseases
by: V. Yu. Pylev, et al.
Published: (2022-12-01)

Pharmacogenetics or predictive genetics? APOE testing blurs the lines
by: Stefania Zampatti, et al.
Published: (2025-07-01)

OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS
by: T. V. Dokukina, et al.
Published: (2016-05-01)

THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING
by: T. V. Dokukina, et al.
Published: (2016-08-01)

Drug-Induced Lung Disease (Organizing Pneumonia) Associated with Mesalazine
by: E. V. Smirnova, et al.
Published: (2022-02-01)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01)

Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01)

Impact of pharmacogenetics on aspirin resistance: a systematic review
by: Gustavo Figueiredo da Silva, et al.
Published: (2023-01-01)

Assessment of Treatment in Inflammatory Bowel Disease Patients Using Steroid Assessment Tool (SAT) in a Tertiary Center from Romania
by: Loredana GORAN, et al.
Published: (2021-06-01)

The efficacy of aminosalicylates in acute radiation enteritis: a systematic review and meta-analysis
by: Zhendong Wu, et al.
Published: (2025-04-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

Pharmacogenetic markers of antipsychotic-induced weight gain: leptin and neuroepeptide Y
by: V. S. Dobrodeeva, et al.
Published: (2021-04-01)

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population
by: K. B. Mirzaev, et al.
Published: (2019-07-01)

Terminal ileitis: Questions of differential diagnosis and prospects for treatment. A review
by: Alexey M. Osadchuk, et al.
Published: (2025-01-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
by: B. I. Kantemirova, et al.
Published: (2021-05-01)

Organo-protective effects of quinapril: pharmacogenetic aspects
by: D. A. Sychev, et al.
Published: (2011-04-01)

Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode
by: D. V. Ivashchenko, et al.
Published: (2019-12-01)

ERADICATION OF H.PYLORI: RISK ASSESSMENT AND POSSIBLE PREVENTION OF DRUG-DRUG INTERACTIONS
by: S. YU. Serebrova, et al.
Published: (2020-05-01)

Pharmacogenetic Study of Anti‐TB Drugs in the Native Ancestry Peruvian Population
by: Luis Jaramillo‐Valverde, et al.
Published: (2025-06-01)

Effective domestic mesalazine in the therapy of ulcerative colitis
by: I. N. Ruchkina, et al.
Published: (2021-06-01)